Home

1 min read

Darzalex Faspro® Now FDA-Approved for Patients with High-Risk Smoldering Myeloma
Source: MMRF Published on 2025-11-06
How the MMRF’s HORIZON One Trial Is Driving Innovation Just One Year In
Source: MMRF Published on 2025-11-06
How the Horizon One Trial Is Driving Innovation Just One Year In
Source: MMRF Published on 2025-11-06
Multiple Myeloma Research Foundation Joins Forces with Patients and Caregivers for Road to Victories Fundraiser
Source: MMRF Published on 2025-11-03
How Horizon Two Will Break New Ground in High-Risk Myeloma: A Q&A with Sham Mailankody, MD
Source: MMRF Published on 2025-10-20
Understanding AML vs. ALL: Navigating the complex field
Source: Published on 2025-07-31
Solving for end-of-life care disparities
Source: Published on 2025-07-30
How humor helped me with cancer
Source: Published on 2025-07-29
What causes acute myeloid leukemia?
Source: Published on 2025-07-28
Holding onto hope: Living with chronic lymphocytic leukemia
Source: Published on 2025-07-24